Walid Kamoun, Vice President and Global Head of Reasearch and Development Oncology at Servier, shared on LinkedIn:
“As I am scouting for new scientific data on brain tumor, I stumbled on this interesting review in Science Translational Medicine.
The Review summarizes the current standard of care and then examines the emerging strategies aimed at these constraints: locoregional delivery technologies, immunotherapy, biomarker-defined precision approaches, and adaptive clinical trial designs.
The authors highlight the translational and clinical studies shaping the field and discuss principles for developing more integrated therapeutic paradigms.
Thanks to Villa et al. for this a detailed review. It is always good to review where we stand.”
Title: Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy
Authors: Genaro R Villa, Ashish D Patel, David A Reardon, E Antonio Chiocca
You can also read ‘Brain Cancer: Causes, Symptoms, Diagnosis, and 2025 Advances in Treatment‘
